by Sam Eskandari | Sep 19, 2018 | News
VANCOUVER, British Columbia, Sept. 19, 2018 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to provide a corporate update on its activities, milestones over the first three quarters of...
by Sam Eskandari | Sep 13, 2018 | News
September 13, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that 3 Carbon Extractions Inc. (“3 CARBON”), an industry leader in regulatory compliant cannabis hydrocarbon...
by Sam Eskandari | Sep 13, 2018 | News
VANCOUVER, British Columbia, Sept. 13, 2018 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that the Company has entered into a Non-Binding Letter of Intent (“LOI”) to sell all of the issued...
by Sam Eskandari | Sep 11, 2018 | News
VANCOUVER, British Columbia, Sept. 11, 2018 — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that 3 Carbon Extractions Inc. (“3 CARBON”), an industry leader in regulatory compliant cannabis...
by Sam Eskandari | Sep 5, 2018 | News
September 5, 2018, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that its subsidiary, 3 Carbon Extractions Inc. (“3 CARBON”), has completed an exclusive marketing rights...
